AVANIR Pharmaceuticals (AVNR)

S&P 500: 843.90
Change: -5.84%

A pharmaceutical company focused on developing, acquiring and commercializing novel therapeutic products for the treatment of chronic diseases.

Recs

Avatar jss6439 (< 20) Submitted: 7/03/07 5:16 PM : Start Price: $2.69 AVNR Score: 45.50

I just sold this stock knowing it is going to underperform.If your'e a player it has its moments but catch on the downside.

Featured Broker Partners